Hilda Wong

554 total citations
18 papers, 433 citations indexed

About

Hilda Wong is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Hilda Wong has authored 18 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Hepatology. Recurrent topics in Hilda Wong's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Mechanisms and Therapy (3 papers). Hilda Wong is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Mechanisms and Therapy (3 papers). Hilda Wong collaborates with scholars based in China, Hong Kong and Australia. Hilda Wong's co-authors include Thomas Yau, Pierre Chan, Sheung Tat Fan, Tzy‐Jyun Yao, Roberta Pang, Ronnie T.P. Poon, Tan To Cheung, Roland Leung, Ronnie T.P. Poon and Joanne Chiu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Surgical Oncology.

In The Last Decade

Hilda Wong

17 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hilda Wong China 10 219 120 117 98 94 18 433
Chiara Cristofori Italy 6 387 1.8× 107 0.9× 150 1.3× 148 1.5× 83 0.9× 14 547
G.K. Abou-Alfa United States 11 266 1.2× 179 1.5× 99 0.8× 101 1.0× 87 0.9× 30 467
Issei Saeki Japan 14 328 1.5× 99 0.8× 66 0.6× 225 2.3× 112 1.2× 53 583
Hiroaki Hagihara Japan 13 253 1.2× 72 0.6× 64 0.5× 159 1.6× 45 0.5× 25 427
Dawn Q. Chong Singapore 10 116 0.5× 115 1.0× 42 0.4× 191 1.9× 51 0.5× 21 471
Naoki Kamachi Japan 12 303 1.4× 97 0.8× 115 1.0× 95 1.0× 81 0.9× 24 367
Marco Sanduzzi‐Zamparelli Spain 10 268 1.2× 78 0.7× 42 0.4× 233 2.4× 40 0.4× 30 424
Yong Le China 10 464 2.1× 131 1.1× 216 1.8× 136 1.4× 129 1.4× 11 652
Tenyu Motoyama Japan 14 487 2.2× 126 1.1× 128 1.1× 295 3.0× 92 1.0× 29 744
Hajime Aino Japan 9 211 1.0× 64 0.5× 55 0.5× 99 1.0× 50 0.5× 10 320

Countries citing papers authored by Hilda Wong

Since Specialization
Citations

This map shows the geographic impact of Hilda Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilda Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilda Wong more than expected).

Fields of papers citing papers by Hilda Wong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hilda Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilda Wong. The network helps show where Hilda Wong may publish in the future.

Co-authorship network of co-authors of Hilda Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Hilda Wong. A scholar is included among the top collaborators of Hilda Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hilda Wong. Hilda Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Chiu, Joanne, Roland Leung, Vikki Tang, et al.. (2019). Changing pattern of recurrences in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy in the era of dual anti-HER2 therapy. Postgraduate Medical Journal. 95(1121). 155–161. 4 indexed citations
2.
Chan, Kwok Ying, Hilda Wong, Terence Yip, et al.. (2014). Effect of erythropoiesis-stimulating agents on hemoglobin level, fatigue and hospitalization rate in renal palliative care patients. International Urology and Nephrology. 46(3). 653–657. 8 indexed citations
3.
4.
Yau, Thomas Cheung, Vikki Tang, Joanne Chiu, Hilda Wong, & Roland Leung. (2014). Efficacy and saftey of capecitabine, oxaliplatin, and irinotecan (xeloxiri) as salvage therapy for patients with treatment-refractory metastatic colorectal cancer: A prospective, open-label, phase II study.. Journal of Clinical Oncology. 32(15_suppl). e14511–e14511. 1 indexed citations
5.
Leung, Roland, B. W. Lang, Hilda Wong, et al.. (2013). Advances in the Systemic Treatment of Neuroendocrine Tumors in the Era of Molecular Therapy. Anti-Cancer Agents in Medicinal Chemistry. 13(3). 382–388. 3 indexed citations
6.
7.
Chiu, Joanne Wing Yan, Tzy‐Jyun Yao, Hilda Wong, et al.. (2012). The use of single‐agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child‐Pugh B liver cirrhosis. Cancer. 118(21). 5293–5301. 56 indexed citations
8.
Wong, Hilda & Thomas Yau. (2012). Targeted Therapy in the Management of Advanced Gastric Cancer: Are We Making Progress in the Era of Personalized Medicine?. The Oncologist. 17(3). 346–358. 50 indexed citations
9.
Wong, Hilda. (2012). Coloncancer in a patient with underlying aplastic anemia: A clinical challenge. World Journal of Clinical Oncology. 3(2). 29–29. 1 indexed citations
10.
Wong, Hilda & Thomas Yau. (2012). Molecular targeted therapies in advanced gastric cancer: does tumor histology matter?. Therapeutic Advances in Gastroenterology. 6(1). 15–31. 30 indexed citations
11.
Wong, Hilda, Kai Pun Wong, Thomas Yau, et al.. (2012). Is There a Role for Unstimulated Thyroglobulin Velocity in Predicting Recurrence in Papillary Thyroid Carcinoma Patients with Detectable Thyroglobulin after Radioiodine Ablation?. Annals of Surgical Oncology. 19(11). 3479–3485. 32 indexed citations
12.
Yau, Thomas, Hilda Wong, Pierre Chan, et al.. (2012). Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease. Investigational New Drugs. 30(6). 2384–2390. 59 indexed citations
13.
Wong, Hilda, Tzy‐Jyun Yao, Joanne Chiu, et al.. (2011). The Outcomes and Safety of Single-Agent Sorafenib in the Treatment of Elderly Patients with Advanced Hepatocellular Carcinoma (HCC). The Oncologist. 16(12). 1721–1728. 54 indexed citations
14.
Wong, Hilda & Thomas Yau. (2011). Review: metronomic chemotherapy for advanced cutaneous angiosarcoma.. PubMed. 9(6). 504–6. 3 indexed citations
15.
Yau, Thomas, Tzy‐Jyun Yao, Pierre Chan, et al.. (2011). The Significance of Early Alpha-Fetoprotein Level Changes in Predicting Clinical and Survival Benefits in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib. The Oncologist. 16(9). 1270–1279. 88 indexed citations
16.
17.
Wong, Hilda, Thomas Yau, Pierre Chan, et al.. (2009). PPI-Delayed Diagnosis of Gastrinoma: Oncologic Victim of Pharmacologic Success. Pathology & Oncology Research. 16(1). 87–91. 11 indexed citations
18.
Yau, Thomas, et al.. (2008). Intramuscular recurrence in a Hepatocellular carcinoma patient with indolent disease course. World Journal of Surgical Oncology. 6(1). 42–42. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiara Cristofori Breakdown of academic impact, for papers by G.K. Abou-Alfa Breakdown of academic impact, for papers by Issei Saeki Breakdown of academic impact, for papers by Hiroaki Hagihara Breakdown of academic impact, for papers by Dawn Q. Chong Breakdown of academic impact, for papers by Naoki Kamachi Breakdown of academic impact, for papers by Marco Sanduzzi‐Zamparelli Breakdown of academic impact, for papers by Yong Le Breakdown of academic impact, for papers by Tenyu Motoyama Breakdown of academic impact, for papers by Hajime Aino
Rankless by CCL
2026